DOI:
10.1055/s-00049561
South Asian Journal of Cancer
LinksClose Window
References
Takada Y, Matsuo K.
Gefitinib, but not erlotinib, is a possible inducer of Fra-1-mediated interstitial lung disease.
Keio J Med 2012;
61 (04) 120-127
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.